New, more diverse image better represents who is affected by Parkinson disease, and how.

Research led by Drs. Laura Ranum and Tao Zu is encouraging for future treatments for a type of ALS and several other neurological diseases.

New study led by Dr. Habibeh Khoshbouei, describes how impairment of dopamine transmission caused by manganese toxicity could potentially be blocked.

Drs. Linda Cottler and Sara Jo Nixon are members of UF's coordinating center team to lead national efforts to identify emerging drug abuse trends.

Dr. Valerie Joers will lead study seeking to identify novel approaches to treat Parkinson’s disease.

New study demonstrates an example of the brain’s ability to shift and utilize different neural circuits to perform a task in order to compensate for brain aging.

In JAMA Neurology editorial, Dr. Michael Jaffee and colleagues discuss REM sleep’s potential impact on general health.

This award will be open to undergraduate students, graduate students, and postdoctoral trainees presenting at the 2020 SfN Conference in October.

How COVID-19 and social isolation are affecting the cognitive and mental wellbeing of older adults is the subject of a new study by UF neuroscientists.

The program trains doctoral students to explore treatments to prevent or slow cognitive aging, mild cognitive impairment and Alzheimer’s disease.